An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder

J Clin Psychopharmacol. 2016 Feb;36(1):88-9. doi: 10.1097/JCP.0000000000000450.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / therapeutic use
  • Bipolar Disorder / drug therapy*
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Female
  • Humans
  • Lurasidone Hydrochloride / administration & dosage*
  • Lurasidone Hydrochloride / therapeutic use
  • Male
  • Middle Aged
  • Outpatients
  • Retrospective Studies
  • Treatment Outcome
  • Young Adult

Substances

  • Antipsychotic Agents
  • Lurasidone Hydrochloride